• Disc Medicine held its annual shareholder meeting on June 18, 2026.
• Shareholders selected Donald Nicholson, John Quisel, Ph.D., and William White to serve as Class III directors through the 2029 annual meeting.
• Shareholders endorsed the company’s executive compensation on an advisory, non-binding basis.
• Shareholders ratified Ernst & Young as independent auditor for the fiscal year ending Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-281096), on June 24, 2026, and is solely responsible for the information contained therein.